The Ranbaxy Science Foundation will be organising its 8th Round Table Conference Programme on "Hepatitis C Infection" on October 15, 2001 in New Delhi. Experts from this field will be making extensive presentations. The programme copy is enclosed for your information.

Programme

0845-0915

Registration

0915-0920

Welcome Address Dr. Nityanand

1920-0925

Introduction of Ranbaxy Science Foundation Dr. O.P. Sood, RSF, New Delhi

0925-0930

Introductory Remarks on Hepatitis C Infection Prof. S.K. Sarin, G.B. Pant Hospital, New Delhi

0930-1115

Session - I (Chariman - Prof. G.P. Talwar, The Talwar Research Foundation, New Delhi)

0930-0950

Biology of HCV Dr. Shobha, Broor, AIIMS, New Delhi

0950-1010

Epidemiology and Mode of Transmission of HCV Dr. V. Arankalle, NIV, Pune

1010-1030

Spectrum of Clinical Presentation of HCV Dr. Yogesh Chawla, PGIMER, Chandigarh

1030-1045

Discussion

1045-1115

Tea / Coffee

1115-1215

Session - II (Chariman - Prof. N.K. Ganguly, ICMR, New Delhi)

1115-1135

Laboratory Diagnosis of HCV Infection Dr. S.P. Thyagarajan, Dr. ALMPG IBMS University Madras

1135-1155

HCV Genotypes and Viral Kinetics Dr. S.K. Panda, AIIMS, New Delhi

1155-1215

Safe Blood and Universal Precautions Dr. Sudershan Kumari, WHO, New Delhi

1215-1255

Session - III (Chairman - Dr. Samir Brahmachari, CBT, Delhi)

1215-1235

Host-Viral Interacations in HCV Pathogensis Dr. Shahid Jameel, ICGEB, New Delhi

1235-1255

Pathology of HCV Dr. Veena Malhotra, G.B. Pant Hospital, New Delhi

1300-1400

Lunch

1400-1500

Session - IV (Chairman - Dr. R.K. Tandon, AIIMS, New Delhi)

1400-1430

Current Therapy for HCV Prof. S.K. Sarin, G.B. Pant Hospital, New Delhi

1430-1500

Treatment in Special Situations Dr. D. Amarapurkar, Bombay Hospital & Medical Research Centre, Mumbai

1500-1600

Session - V (Chairman - Prof. M.P. Sharma, AIIMS, New Delhi)

1500-1520

Emerging Therapies for HCV Dr. S.K. Acharya, AIIMS, New Delhi

1520-1540

Antiviral Therapies to Prevent Development of HCC Dr. Sameer Shah, Mumbai

1540-1600

Current Status of HCV Vaccine Development Dr. Shahid Jameel, ICGEB, New Delhi

1600-1615

Tea / Coffee

1615-1700

Session - VI : Frequently asked Questions Moderator : Dr. S.K. Sarin, Dr. G. Chandy, CMC, Vellore

Dr. P. Kar, MAMC, New Delhi, Dr. G. Chaudhary, SGPGIMS, Lucknow Dr. Yogesh. Chawla, PGIMER, Chandigarh

Dr. R.R. Rai, S.M.S. Medical Colege, Jaipur

1700-1710

Concluding Remarks Prof. S.K. Sarin

1710

Vote of Thanks Dr. O.P. Sood

For More Information Contact:

Krishnan Ramalingam: krishnanr@ranbaxy.co.in .